Literature DB >> 28477317

TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma.

Raissa C Andrade1, Maria A F D de Lima2, Paulo A S de Faria3, Fernando R Vargas4,5,6.   

Abstract

Li-Fraumeni syndrome is a rare hereditary cancer predisposition syndrome associated with germline pathogenic variants in TP53 gene. The phenotype may vary from classical to variant forms, known as Li-Fraumeni-like phenotypes. We searched for pathogenic variants in TP53 in a 14 year-old female diagnosed with fibrolamellar hepatocellular carcinoma, a rare subtype of hepatocellular carcinoma. The proband is a heterozygote carrier of the TP53 c.467G>A (p.Arg156His) in exon 5, and her mother is an asymptomatic carrier. Analysis of tumor DNA disclosed an additional somatic mutation in TP53, c.461G>A; p.Gly154Asp. The TP53 germline and somatic pathogenic variants may have acted as possible driver mutations, resulting in genomic instability and tumor development. The fibrolamellar subtype of hepatocellular carcinoma may be part of the broad spectrum of tumors associated with Li-Fraumeni phenotype.

Entities:  

Keywords:  Fibrolamellar hepatocellular carcinoma; Li-Fraumeni syndrome; Li-Fraumeni-like syndrome; TP53 gene

Mesh:

Substances:

Year:  2018        PMID: 28477317     DOI: 10.1007/s10689-017-9998-5

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  16 in total

1.  2009 version of the Chompret criteria for Li Fraumeni syndrome.

Authors:  Julie Tinat; Gaelle Bougeard; Stéphanie Baert-Desurmont; Stéphanie Vasseur; Cosette Martin; Emilie Bouvignies; Olivier Caron; Brigitte Bressac-de Paillerets; Pascaline Berthet; Catherine Dugast; Catherine Bonaïti-Pellié; Dominique Stoppa-Lyonnet; Thierry Frébourg
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

2.  Genomic analysis of fibrolamellar hepatocellular carcinoma.

Authors:  Lei Xu; Florette K Hazard; Anne-Flore Zmoos; Nadine Jahchan; Hassan Chaib; Phillip M Garfin; Arun Rangaswami; Michael P Snyder; Julien Sage
Journal:  Hum Mol Genet       Date:  2014-08-13       Impact factor: 6.150

3.  Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.

Authors:  Matthew B Yurgelun; Serena Masciari; Victoria A Joshi; Rowena C Mercado; Noralane M Lindor; Steven Gallinger; John L Hopper; Mark A Jenkins; Daniel D Buchanan; Polly A Newcomb; John D Potter; Robert W Haile; Raju Kucherlapati; Sapna Syngal
Journal:  JAMA Oncol       Date:  2015-05       Impact factor: 31.777

4.  Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.

Authors:  Gaëlle Bougeard; Mariette Renaux-Petel; Jean-Michel Flaman; Camille Charbonnier; Pierre Fermey; Muriel Belotti; Marion Gauthier-Villars; Dominique Stoppa-Lyonnet; Emilie Consolino; Laurence Brugières; Olivier Caron; Patrick R Benusiglio; Brigitte Bressac-de Paillerets; Valérie Bonadona; Catherine Bonaïti-Pellié; Julie Tinat; Stéphanie Baert-Desurmont; Thierry Frebourg
Journal:  J Clin Oncol       Date:  2015-05-26       Impact factor: 44.544

5.  Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.

Authors:  Joshua N Honeyman; Elana P Simon; Nicolas Robine; Rachel Chiaroni-Clarke; David G Darcy; Irene Isabel P Lim; Caroline E Gleason; Jennifer M Murphy; Brad R Rosenberg; Lydia Teegan; Constantin N Takacs; Sergio Botero; Rachel Belote; Soren Germer; Anne-Katrin Emde; Vladimir Vacic; Umesh Bhanot; Michael P LaQuaglia; Sanford M Simon
Journal:  Science       Date:  2014-02-28       Impact factor: 47.728

6.  Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features.

Authors:  J R Craig; R L Peters; H A Edmondson; M Omata
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

Review 7.  Genetics and epigenetics of liver cancer.

Authors:  Cigdem Ozen; Gokhan Yildiz; Alper Tunga Dagcan; Dilek Cevik; Aysegul Ors; Umur Keles; Hande Topel; Mehmet Ozturk
Journal:  N Biotechnol       Date:  2013-02-04       Impact factor: 5.079

8.  Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

Authors:  J M Birch; A L Hartley; K J Tricker; J Prosser; A Condie; A M Kelsey; M Harris; P H Jones; A Binchy; D Crowther
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

9.  Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas.

Authors:  Perumal Vivekanandan; Michael Torbenson
Journal:  Mod Pathol       Date:  2008-02-08       Impact factor: 7.842

10.  High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort.

Authors:  Gillian Mitchell; Mandy L Ballinger; Stephen Wong; Chelsee Hewitt; Paul James; Mary-Anne Young; Arcadi Cipponi; Tiffany Pang; David L Goode; Alex Dobrovic; David M Thomas
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

View more
  1 in total

Review 1.  Systems Challenges of Hepatic Carcinomas: A Review.

Authors:  Dhatri Madduru; Johny Ijaq; Sujata Dhar; Saumyadip Sarkar; Naresh Poondla; Partha S Das; Silvia Vasquez; Prashanth Suravajhala
Journal:  J Clin Exp Hepatol       Date:  2018-05-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.